Literature DB >> 20006572

Inactivation of nitric oxide by cytochrome c oxidase under steady-state oxygen conditions.

David C Unitt1, Veronica S Hollis, Miriam Palacios-Callender, Nanci Frakich, Salvador Moncada.   

Abstract

We have developed a respiration chamber that allows intact cells to be studied under controlled oxygen (O(2)) conditions. The system measures the concentrations of O(2) and nitric oxide (NO) in the cell suspension, while the redox state of cytochrome c oxidase is continuously monitored optically. Using human embryonic kidney cells transfected with a tetracycline-inducible NO synthase we show that the inactivation of NO by cytochrome c oxidase is dependent on both O(2) concentration and electron turnover of the enzyme. At a high O(2) concentration (70 microM), and while the enzyme is in turnover, NO generated by the NO synthase upon addition of a given concentration of l-arginine is partially inactivated by cytochrome c oxidase and does not affect the redox state of the enzyme or consumption of O(2). At low O(2) (15 microM), when the cytochrome c oxidase is more reduced, inactivation of NO is decreased. In addition, the NO that is not inactivated inhibits the cytochrome c oxidase, further reducing the enzyme and lowering O(2) consumption. At both high and low O(2) concentrations the inactivation of NO is decreased when sodium azide is used to inhibit cytochrome c oxidase and decrease electron turnover. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006572     DOI: 10.1016/j.bbabio.2009.12.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Short-term hypoxic vasodilation in vivo is mediated by bioactive nitric oxide metabolites, rather than free nitric oxide derived from haemoglobin-mediated nitrite reduction.

Authors:  Michele Umbrello; Alex Dyson; Bernardo Bollen Pinto; Bernadette O Fernandez; Verena Simon; Martin Feelisch; Mervyn Singer
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

Review 2.  "Quantum Leap" in Photobiomodulation Therapy Ushers in a New Generation of Light-Based Treatments for Cancer and Other Complex Diseases: Perspective and Mini-Review.

Authors:  Luis Santana-Blank; Elizabeth Rodríguez-Santana; Karin E Santana-Rodríguez; Heberto Reyes
Journal:  Photomed Laser Surg       Date:  2016-02-18       Impact factor: 2.796

3.  Monitoring yeast mitochondria with peroxiredoxin-based redox probes: the influence of oxygen and glucose availability.

Authors:  Daniel Pastor-Flores; Katja Becker; Tobias P Dick
Journal:  Interface Focus       Date:  2017-04-06       Impact factor: 3.906

Review 4.  Regulation of mitochondrial processes by protein S-nitrosylation.

Authors:  Claude A Piantadosi
Journal:  Biochim Biophys Acta       Date:  2011-03-21

5.  Kolaviron was protective against sodium azide (NaN3) induced oxidative stress in the prefrontal cortex.

Authors:  Olayemi J Olajide; Bernard U Enaibe; Oluwamolakun O Bankole; Oluwole B Akinola; Babafemi J Laoye; Olalekan M Ogundele
Journal:  Metab Brain Dis       Date:  2015-04-29       Impact factor: 3.584

6.  Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease.

Authors:  Sujay Guha; Chigoziri Konkwo; Manuela Lavorato; Neal D Mathew; Min Peng; Julian Ostrovsky; Young-Joon Kwon; Erzsebet Polyak; Richard Lightfoot; Christoph Seiler; Rui Xiao; Michael Bennett; Zhe Zhang; Eiko Nakamaru-Ogiso; Marni J Falk
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

7.  The Chemical Interplay between Nitric Oxide and Mitochondrial Cytochrome c Oxidase: Reactions, Effectors and Pathophysiology.

Authors:  Paolo Sarti; Elena Forte; Alessandro Giuffrè; Daniela Mastronicola; Maria Chiara Magnifico; Marzia Arese
Journal:  Int J Cell Biol       Date:  2012-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.